– Patients treated in “real-life” audiology centers in 2025 achieved even greater clinical improvements then the impressive results of the published General Hospital study (Tor Vergata, 2022-24).
– The ease and speed of use and its superior performance render Acufree a unique therapy.
– Patients as well as audiology centers appreciate the treatment and monitoring advantages compared with more complex and costly psycho-perceptive or behavioral (CBT) therapies.
– Acufree is now ready, willing & able to assist millions of sufferers all over Europe, to fight this growing neuro-acoustic pathology and improve the quality of their daily life.
Acufree:
A Europe-wide tinnitus solution for 2026
Request informationRecommended treatmentSuccess and improv 2025
Acufree :
A Europe-wide tinnitus solution for 2026
Request information
Recommended treatment
Success and improv 2025
The Year 2025 delivered the confirmation of Acufree’s uniqueness & superior performance
Acufree has obtained the CE 2A MARK CERTIFICATE boosting its Pan-European potential
Development
Fully certified CE MARK Medical Device with unique synchronous 3-way active elements offering maximum ease-of-use to patient and doctor or therapist.
Safety
Accuracy and effectiveness of specific electromagnetic fields are applied to the auditory system based on strong conclusive evidence of total safety
Results
Progressive reduction in the intensity of perceived symptoms, and progressive increase in the duration of relief obtained with Acufree.
Acufree
Acufree is our non-invasive and customizable remedy that achieves a progressive, significant and lasting reduction in the effects of tinnitus, unlike other current, complex and costly treatments.
Tinnitus is an auditory disorder consisting of noises (whistling, buzzing, rattling, pulsating, etc.) that occur at different intensities and tend to settle and compound over time, eventually becoming chronic, impairing quality of life.
Acufree has demonstrated in certified clinical trials, both in hospital environment and in real-life hearing care centers, that it can improve on the results obtained so far in the battle against tinnitus by achieving symptom reduction and prolongation of beneficial effects even after 1 year.
Hence the claim of “progressive and lasting remedy to tinnitus disorders.”
Learn more
The Situation
Tinnitus: around the world, every day, millions of people suffer a loss of quality of life due to this complex, multiple-origin, partially unknown, hitherto incurable condition.
Total World about 750 Million (NB. data not including occasional tinnitus phenomena).
Europe
78
million / 764 million
Australia
5
million / 25 million
Latin America
178
million / 642 million
Africa
89
million / 1.2 billion
U.S.A.
39
million / 329 million
China
146
million / 1.4 billion
Asia
177
million / 4.5 billion
India
38
million / 1.3 billion
Intellectual Property
The technology developed by our company is supported by an “intellectual property portfolio.”
Tinnitech Group has a policy of extensive patent coverage of its research, technology and product.
Technology
Tinnitech’s innovative Anti-ACUFENI treatment uses cutting-edge electronics that through the integration of auditory, inductive and capacitive tools triggers beneficial effects, both physiological and psycho-perceptive.
The combined delivery of these active elements develops effective synchronous multimodal therapy.
Meetings with the expert:
Every Tuesday from 3 p.m. to 7 p.m.
For information on the operation of ACUFREE or treatment features.
call the 3398105551
Headquarters
Tecnopolo Romano – c/o Innova Incubator Via G. Peroni 386 – 00131 Rome
Northern Italy Headquarters
c/o Ecupharma SRL Via Newton 9a – 20016 Pero, Milan
Direct telephone
+39 3355273686
Administration
06/ 40040358
